UPDATE: Deutsche Bank Raises PT to $65 on Express Scripts


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Deutsche Bank raises its price target on Buy-rated Express Scripts (NASDAQ: ESRX) to $65 from $59.50, reflecting several positive data points recently that may result in the FTC approval of the MHS transaction in the near term. Deutsche Bank notes, "We introduce our PF EPS for FY12E of $3.65 and FY13E of $4.65 and raise our PT from $59.50 to $65.00 (14x FY13E EPS). The combination of ESRX and MHS should allow the PF company to differentiate itself in several key ways. Strategically, the combined entities' focus on behavioral insights and health outcomes should allow it to increase patient adherence and bend the healthcare cost curve."ESRX closed at $53.65 a share on Friday.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetReiterationPre-Market OutlookAnalyst RatingsDeutsche Bank